TRIFLUOPERAZINE vs LOW‐POTENCY ANTIPSYCHOTIC DRUGS
Adverse effects ‐ movement disorders ‐ At least one movement disorder · patients with schizophrenia
Trifluoperazine showed no clear difference in adverse events: 2.a. Specific ‐ movement disorders ‐ at least one… compared with low‐potency antipsychotic drugs (low certainty).
1 finding from 1 review
- Trifluoperazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia 2014 · Cochrane Headline outcomes onlyRR 2.08 [0.78, 5.55]2 studies · 123 participantsLow